Status:
COMPLETED
"COVID-19 and Diabetes Outcomes"
Lead Sponsor:
Nantes University Hospital
Conditions:
Coronavirus
Diabetes
Eligibility:
All Genders
Brief Summary
COVID-19 (Coronavirus Disease-2019) is a life-threatening infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that appeared in December 2019 in the Wuhan dist...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients admitted in a hospital center since 10th march 2020
- Patients with COVID19 with biological proof (specific PCR) or with clinical and radiological diagnosis.
- Patient with diabetes known before the admission
- New onset diabetes discovered at admission (HbA1c value strictly greater than 6.5%)
- exclusion criteria
- subjects opposed to the use of their data
- minors, adults under guardianship, protected persons
- subject having already been included in the CORONADO study (subject readmitted after discharge following the initial stay). Only the data of the first stay will be maintained.
Exclusion
Key Trial Info
Start Date :
March 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
5309 Patients enrolled
Trial Details
Trial ID
NCT04324736
Start Date
March 10 2020
End Date
December 31 2020
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nantes
Nantes, France, 44000